<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02258919</url>
  </required_header>
  <id_info>
    <org_study_id>163/14</org_study_id>
    <secondary_id>32003B_150009</secondary_id>
    <nct_id>NCT02258919</nct_id>
  </id_info>
  <brief_title>Decompressive Hemicraniectomy in Intracerebral Hemorrhage</brief_title>
  <acronym>SWITCH</acronym>
  <official_title>Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spontaneous intracerebral hemorrhage (ICH) remains a devastating disease with mortality rates
      up to 52% at 30 days. It is a major public health problem with an annual incidence of 10-30
      per 100'000 population, accounting for 2 million (10-15%) of about 15 million strokes
      worldwide each year. The strategy of decompressive craniectomy (DC) is beneficial in patients
      with malignant middle cerebral artery (MCA) infarction. Based on the common
      pathophysiological mechanisms of these two conditions, this procedure is also frequently
      performed in patients with ICH, but is has not yet been investigated in a randomized trial.

      The primary objective of this randomized controlled trial is to determine whether
      decompressive surgery and best medical treatment in patients with spontaneous ICH will
      improve outcome compared to best medical treatment only.

      Secondary objectives are to analyze mortality, dependency and quality of life. Safety
      endpoints are to determine cause of any mortality and the rate of medical and surgical
      complications after DC compared with best medical treatment alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background

      Spontaneous intracerebral hemorrhage (ICH) remains a devastating disease with mortality rates
      up to 52% at 30 days. It is a major public health problem with an annual incidence of 10-30
      per 100'000 population, accounting for 2 million (10-15%) of about 15 million strokes
      worldwide each year. One-third of patients with ICH die within one month and the majority of
      survivors remain handicapped. Neurological injury resulting from ICH is mediated by the mass
      effect of the hematoma, secondary to brain edema and/or both mechanisms. Treatment of ICH is
      one of the major unresolved issues of acute stroke treatment. The International Surgical
      Trials in Intracerebral Hemorrhage (STICH and STICH II) and other randomized controlled
      trials did not show any superiority of surgical treatment compared to conservative treatment
      approaches. Nevertheless, surgical treatment in ICH remains a matter of debate and attempts
      to improve outcome using surgical therapy are still ongoing. Many efforts are made to
      minimize the invasiveness of operative procedures such as clot evacuation. However, direct
      surgical interventions aiming at the removal of the hematoma have failed to improve
      neurological outcome for most subtypes of ICH, especially deep-seated hematomas. The trauma
      of open craniotomy and especially trauma to the brain parenchyma for hematoma evacuation are
      considered to outweigh the benefits of surgery.

      Decompressive craniectomy (DC), which is beneficial in patients with malignant middle
      cerebral artery (MCA) infarction, may indirectly relieve the mass effect, decrease
      perihematomal tissue pressure, improve blood flow, reduce secondary brain damage and improve
      outcome without further damage to the brain due to surgery. Consequently, DC has been
      established as a standard surgical therapy for patients with malignant MCA infarction with a
      level of evidence grade 2. Decompressive craniectomy for acute stroke is one of the most
      effective treatments available: the number needed to be treated to save one patient's life is
      2. Decompressive craniectomy is also a standard therapeutic procedure in patients with ICH
      due to sinus venous thrombosis, herpes encephalitis, or ruptured intracranial aneurysms. In
      patients with traumatic brain injury DC is a standard therapy to reduce elevated intracranial
      pressure. The investigators and others assessed whether DC is feasible and beneficial in
      patients with spontaneous intracranial hemorrhage. The investigators showed in a previous
      retrospective trial that DC in patients with supratentorial ICH is safe and feasible and may
      reduce mortality compared to matched controls with best medical treatment alone. The
      limitations of the feasibility trial are its retrospective design, the small sample size and
      the inhomogeneity of the patient cohort with respect to the origin of ICH. Furthermore, in
      the feasibility trial the decision for DC was taken on an individual basis rather than
      according to a strict protocol, introducing a potential selection bias. Nevertheless, the
      preliminary results are encouraging. Recently, three human trials, one animal study, one
      meta-analysis, and one original contribution have been published on this topic. However, no
      prospective randomized trial has ever assessed whether DC without hematoma evacuation in
      patients with acute ICH improves outcome. All recent studies showed promising results and all
      call for the initiation of a randomized controlled trial.

      Objective

      The primary objective of this randomized controlled trial is to determine whether
      decompressive surgery and best medical treatment in patients with spontaneous ICH will
      improve outcome compared to best medical treatment only.

      Secondary objectives are to analyze mortality, dependency and quality of life. Safety
      endpoints are to determine cause of any mortality and the rate of medical and surgical
      complications after DC compared with best medical treatment alone.

      Methods

      All patients with a suspected intracerebral hemorrhage will be considered for this trial.
      Randomization of eligible patients will be performed within 66 hours after ictus in patients
      with stable clot volume and surgery no later than 6 hours after randomization. Patients
      randomized to the control group will receive best medical treatment according to
      international guidelines. Patients randomized to the treatment group will receive best
      medical treatment and a DC of at least 12cm according to institutional guidelines and a
      surgical protocol. The primary outcome death and dependency at 6 months will be assessed by a
      trained person unaware of treatment allocation. Favorable outcome is defined as a modified
      Rankin Scale (mRS) score of 0 to 4, poor outcome as modified Rankin Scale score of 5 or 6.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score in modified Rankin Scale (mRS)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessed by telephone interview</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>7 days, 30 days, 180 days, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mRS score of 0-3 versus 4-6</measure>
    <time_frame>30 days, 180 days, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Categorical shift in mRS score</measure>
    <time_frame>180 days, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>180 days, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death and intracranial hemorrhage</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cerebral Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Decompressive craniectomy and best medical treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Decompressive craniectomy and best medical treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Best medical treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Best medical treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Decompressive craniectomy (DC) and best medical treatment</intervention_name>
    <description>Decompressive craniectomy:
All patients in the treatment group will receive DC of at least 12 cm according to institutional guidelines and a published surgical protocol.
Best medical treatment:
Best medical treatment is based on American Heart Association/American Stroke Association (AHA/ASA) and European Stroke Organisation (ESO) as published in the current protocol from 2010 and 2014 respectively.</description>
    <arm_group_label>Decompressive craniectomy and best medical treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Best medical treatment</intervention_name>
    <description>Best medical treatment is based on American Heart Association/American Stroke Association (AHA/ASA) and European Stroke Organisation (ESO) as published in the current protocol from 2010 and 2014 respectively.</description>
    <arm_group_label>Best medical treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent of the patient or of patient's next of kin plus consent of an
             independent physician if patient is unable to consent before randomization

          -  Acute stroke syndrome due to a spontaneous ICH, defined as the sudden occurrence of
             bleeding into the parenchyma of the basal ganglia and/or thalamus that may extend into
             the ventricles and into the cerebral lobes, and into the subarachnoid space, confirmed
             by clinical history and imaging

          -  Age: ≥18 to ≤75 years

          -  Glasgow coma scale (GCS) &lt;14 and &gt;7

          -  Neurological deficit with a NIHSS score of ≥10 and ≤30

          -  Able to be randomly assigned to surgical treatment within 66 hours after ictus

          -  Surgery performed not later than 6 hours after randomization

          -  Volume of hematoma ≥30 ml and ≤100 ml

          -  Stable clot volume

          -  International normalized ratio (INR) &lt;1.5, thrombocytes &gt;100 T/ml

        Exclusion Criteria

          -  ICH due to known or suspected structural abnormality in the brain (e.g., intracranial
             aneurysm, brain arteriovenous malformation, brain tumor) or brain trauma, or previous
             stroke thrombolysis

          -  Cerebellar or brainstem hemorrhage

          -  Exclusive lobar hemorrhage

          -  Known advanced dementia or significant pre-stroke disability

          -  Concomitant medical illness that would interfere with outcome assessment and follow-up

          -  Randomization not possible within 66 hours after ictus

          -  Pregnancy

          -  Prior major brain surgery within &lt;6 month or prior DC

          -  Foreseeable difficulties in follow-up due to geographic reasons

          -  Known definite contraindication for a surgical procedure

          -  A very high likelihood that the patient will die within the next 24 hours on the basis
             of clinical and/or radiological criteria

          -  Previous participation in this trial or in another ongoing investigational trial

          -  Prior symptomatic ICH

          -  ICH secondary to thrombolysis

          -  Bilateral areactive pupils
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urs Fischer, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dep. of Neurology, Inselspital Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jürgen Beck, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dep. of Neurosurgery, Inselspital Bern</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilie Seydoux, PhD</last_name>
    <phone>+41 632 60 83</phone>
    <email>emilie.seydoux@insel.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefanie Lerch, PhD</last_name>
    <phone>+41 632 73 09</phone>
    <email>stefanie.lerch@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinik für Neurochirurgie, Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Martin Ortler, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Neurochirurgie, Kepler Universitätsklinikum Linz</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andreas Gruber, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Daniel Strbian, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondation Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikael Mazighi, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum Schleswig Holstein</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig Holstein</state>
        <zip>23562</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jan Leppert, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirugie, Helios Klinikum Erfurt</name>
      <address>
        <city>Erfurt</city>
        <state>Thüringen</state>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Rüdiger Gerlach, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie Uniklinik RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gerrit Schubert, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Peter Vajkoczy, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Neurochirurgie, Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Erdem Güresir, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kerim Beseoglu, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik, Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Hagen Huttner, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum Essen (AöR)</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ramazan Jabbarli, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zentrum der Neurologie und Neurochirurgie, Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian Senft, Prof. Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roland Rölz, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurochirurgische Klinik, Universitätsklinikum Gießen und Marburg UKGM</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Karsten Schöller, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsmedizin Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dorothee Mielke, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Wolfgang Deinsberger, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurochirurgische Klinik, Universitätsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Florian Ringel, Prof. Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurochirurgische Klinik, Universitätsklinikum Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Daniel Hänggi, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. of Neurosurgery, Klinikum rechts der Isar der Technischen Universität München</name>
      <address>
        <city>Munich</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jens Lehmberg, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Allgemeine Neurologie, Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jens Minnerup, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Thomas Westermaier, PD Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center Amsterdam, Department of Neurology</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jonathan Coutinho, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht, Department of Neurology, Department of Neurosurgery</name>
      <address>
        <city>Utrecht</city>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jaap Kappelle, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bart Van der Zwan, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicio de Neurocirurgía Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fernando Muñoz Hernández, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicio de Neurocirurgía Bellvitge Hospital</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jose Luis Sanmillàn Blasco, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicio de Neurología, Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Exuperio Díez Tejedor, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicios de Neurología, Neurocirugía y Cuidados Intensivos del Hospital Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Javier De la Torre Laviana, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. of Neurology / Dep. of Neurosurgery, Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilie Seydoux, PhD</last_name>
      <phone>+41 632 60 83</phone>
      <email>emilie.seydoux@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Urs Fischer, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jürgen Beck, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. of Clinical Neuroscience, Service of Neurosurgery</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marco Corniola, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. of Neurosurgery, Kantonsspital Luzern</name>
      <address>
        <city>Lucerne</city>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Karl Kothbauer, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. Neurosurgery, Ospedale Regionale di Lugano</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pietro Scarone, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dep. of Neurosurgery, University Hospital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.switch-trial.ch</url>
    <description>Website of the trial</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2014</study_first_submitted>
  <study_first_submitted_qc>October 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2014</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intracerebral hemorrhage</keyword>
  <keyword>Decompressive craniectomy</keyword>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Acute stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

